- Home
- EE vs CRMD Comparison
EE vs CRMD Comparison
Compare EE & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EE
- CRMD
- Stock Information
- Founded
- EE 2003
- CRMD 2006
- Country
- EE United States
- CRMD United States
- Employees
- EE N/A
- CRMD N/A
- Industry
- EE Oil/Gas Transmission
- CRMD Biotechnology: Pharmaceutical Preparations
- Sector
- EE Utilities
- CRMD Health Care
- Exchange
- EE Nasdaq
- CRMD Nasdaq
- Market Cap
- EE 779.2M
- CRMD 865.2M
- IPO Year
- EE 2022
- CRMD 2010
- Fundamental
- Price
- EE $27.59
- CRMD $11.31
- Analyst Decision
- EE Buy
- CRMD Strong Buy
- Analyst Count
- EE 7
- CRMD 8
- Target Price
- EE $32.86
- CRMD $17.57
- AVG Volume (30 Days)
- EE 360.3K
- CRMD 2.6M
- Earning Date
- EE 11-05-2025
- CRMD 10-29-2025
- Dividend Yield
- EE 1.16%
- CRMD N/A
- EPS Growth
- EE 18.98
- CRMD N/A
- EPS
- EE 1.33
- CRMD 0.79
- Revenue
- EE $987,637,000.00
- CRMD $121,484,498.00
- Revenue This Year
- EE $29.31
- CRMD $480.51
- Revenue Next Year
- EE $13.99
- CRMD $59.81
- P/E Ratio
- EE $20.83
- CRMD $14.24
- Revenue Growth
- EE 9.86
- CRMD 14970.29
- 52 Week Low
- EE $21.29
- CRMD $5.60
- 52 Week High
- EE $32.99
- CRMD $17.43
- Technical
- Relative Strength Index (RSI)
- EE N/A
- CRMD 42.51
- Support Level
- EE N/A
- CRMD $11.05
- Resistance Level
- EE N/A
- CRMD $11.71
- Average True Range (ATR)
- EE 0.00
- CRMD 0.49
- MACD
- EE 0.00
- CRMD 0.01
- Stochastic Oscillator
- EE 0.00
- CRMD 20.90
About EE Excelerate Energy Inc.
Excelerate Energy Inc offers LNG solutions, providing integrated services along the LNG value chain. It offers a full range of regasification services, from FSRUs to infrastructure development, to LNG and natural gas supply. Its business spans the globe, with a regional presence in 11 countries and an operational presence in Argentina, Bangladesh, Brazil, Finland, Germany, Pakistan, the United Arab Emirates (UAE), and the United States.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.